Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop therapeutic products.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Silverback Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Silverback Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.